You just read:

Veloxis Pharmaceuticals A/S and Endo Ventures Limited Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Envarsus XR® in Canada

News provided by

Veloxis Pharmaceuticals A/S

06 Jun, 2017, 14:59 ET